Related Experiment Videos
Lipid abnormalities associated with end-stage renal disease
1Division of Nephrology, Department of Internal Medicine, University of Virginia Health System, Charlottesville, Virginia 22908, USA.
Seminars in Dialysis
|January 21, 2006
Summary
Patients on dialysis often have abnormal lipid levels, including high triglycerides and lipoprotein(a), increasing atherosclerosis risk. Understanding these dyslipidemias is crucial for managing cardiovascular disease in renal replacement therapy patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Clinical Biochemistry
Background:
- Chronic renal replacement therapy (RRT) is associated with a high prevalence of dyslipidemia.
- Key abnormalities include elevated triglyceride-rich apolipoprotein B particles, leading to increased non-high-density lipoprotein (HDL) levels.
- Dialysis modality (peritoneal vs. hemodialysis) and comorbidities like diabetes further influence lipid profiles.
Purpose of the Study:
- To review the pathogenesis of lipid abnormalities in patients undergoing chronic renal replacement therapy.
- To examine the role of these dyslipidemias in the atherosclerotic process.
Main Methods:
- Literature review focusing on lipid metabolism in end-stage renal disease (ESRD).
- Analysis of factors modifying lipid profiles, including dialysis type and comorbidities.
- Examination of atherogenic lipoproteins such as lipoprotein(a) (Lp(a)) and oxidized low-density lipoprotein (LDL).
Main Results:
- ESRD patients exhibit increased concentrations of triglyceride-rich apolipoprotein B particles and non-HDL cholesterol.
- Elevated levels of highly atherogenic lipoprotein(a) (Lp(a)) and oxidized low-density lipoprotein (LDL) are observed.
- Lipid profiles are significantly impacted by dialysis method and the presence of diabetes.
Conclusions:
- Dyslipidemia is a significant complication of chronic renal replacement therapy.
- Specific lipid abnormalities in ESRD patients contribute to their high risk of atherosclerosis.
- Further research into managing these lipid disorders is essential for improving cardiovascular outcomes.
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...